2016年12月8日上午，由中国和丹麦两国合作共建的“药事监管科学中心”首次联席会议在复旦大学药学院科研楼晶晖厅举行。此次会议的召开，标志着由国家食品药品监督管理总局药品审评中心支持、诺和诺德制药公司赞助、复旦大学和哥本哈根大学共同参与的“中丹药事监管科学中心”正式启动。
中心指导委员会共同主席、复旦大学副校长桂永浩教授，国家食品药品监督管理总局药品审评中心首席科学家何如意博士，哥本哈根大学健康与医学科学学院副院长Sven Frokjaer教授和药学系主任Flemming Madsen教授，诺和诺德制药公司学术合作副总裁Boerge Diderichsen博士和法规事务与情报监管副总裁Jens Heisterberg博士、诺和诺德中国研发中心总裁王保平博士，复旦大学药学院院长王明伟研究员、副院长侯爱君教授和上海药物创制产业化中心主任邵黎明教授出席了会议。会议由桂永浩副校长主持。
王明伟研究员、Sven Frokjaer教授和Boerge Diderichsen博士首先分别介绍了复旦大学药学院、哥本哈根大学健康与医学科学学院和诺和诺德公司的现状与发展前景，随后三方代表就在监管科学领域开展课程共享、师资互访、学生交流和学术研究等方面的全面合作进行了广泛而深入的讨论，并就今后几年的工作目标和行动方案等实施细节达成一致。本次会议还酝酿了中心指导委员会、协调委员会和咨询委员会的作用、职责和人选，并商定了下一次会议的地点与时间。
诺和诺德（中国）制药有限公司注册事务总监王淑芳博士和战略项目规划经理孙超博士，复旦大学药学院院长助理李嫣副教授、临床药学与药事管理教研室高原副研究员、洪兰讲师和学院外事秘书翟露露以及上海医药临床研究中心资深医学顾问许俊才医师应邀参加了讨论。
Sino-Danish Regulatory Science Center joint meeting held at Fudan School of Pharmacy
In the morning of December 8, 2016, the first joint meeting of “Sino-Danish Regulatory Science Center” was held at School of Pharmacy, Fudan University, thereby signifying the formal inauguration of this international platform supported by Center for Drug Evaluation, China Food and Drug Administration, sponsored by Novo Nordisk A/S and jointly operated by Fudan University and University of Copenhagen.
Among the attendants were Professor Yonghao Gui (Vice President of Fudan University and Joint Chair of the Steering Group of Sino-Danish Regulatory Science Center), Dr. Ruyi He (Chief Scientist of Center for Drug Evaluation, China Food and Drug Administration), Professor Sven Frokjaer (Vice Dean, Faculty of Health and Medical Sciences, University of Copenhagen) and Professor Flemming Madsen (Head of Pharmacy Department, University of Copenhagen), Drs. Boerrge Diderichsen (Vice President, R&D Outreach) and Jens Heisterberg (Vice President, Regulatory Intelligence) of Novo Nordisk A/S, Dr. Baoping Wang (President of Novo Nordisk China R&D Center in Beijing), Drs. Ming-Wei Wang (Dean), Aijun Hou (Vice Dean) and Liming Shao (Director, Shanghai Drug Discovery and Development Center) from School of Pharmacy, Fudan University. Professor Yonghao Gui chaired the meeting.
The meeting began with general introductions of Fudan School of Pharmacy, Faculty of Health and Medical Sciences at University of Copenhagen and Novo Nordisk A/S by Drs. Ming-Wei Wang, Sven Frokjaer and Boerge Diderichsen, respectively. Then, representatives of the three organizations discussed in detail about setting up comprehensive collaborations in regulatory science covering course sharing, faculty visits, student exchanges and academic research, etc. An agreement was reached relative to operational goals and implementing plans of the center in the next few years. The roles, responsibilities and candidates of the steering group, coordination committee and advisory board were suggested so did the date and venue of the next meeting.
Drs. Shufang Wang (Director of Registration) and Chao Sun (Strategic Project Development Manager) of Novo Nordisk China, Drs. Yan Li (Assistant Dean), Yuan Gao (Associate Professor), Lan Hong (Assistant Professor) and Ms. Lulu Zhai (Foreign Affairs Assistant) of Fudan School of Pharmacy, as well as Dr. Jack (Juncai) Xu (Senior Medical Advisor, Shanghai Clinical Research Center), attended the meeting by invitation.
（供稿：洪兰）
